Sid Taubenfeld is the CEO of TO Pharma, the Medical and Research division of Tikun Olam USA. Mr. Taubenfeld started his career as a clinical pharmacist at Bellevue Hospital before becoming buyside healthcare equities research analyst and portfolio manager. He has worked at Balyasny Asset Management (BAM), RH Capital, Scopia Capital, PAW Partners and Celsion Corporation. Mr. Taubenfeld received his degree from the Brooklyn College of Pharmacy.